Investigator, Lady Davis Institute
Department of Oncology, Division of Radiation Oncology
Associate Professor of the Department of Oncology, McGill University
Dr. Tamim Niazi received his Doctor of Medicine and Master of Surgery (MDCN) designation from McGill University in 2001. He did his internship and residency at the McGill University Health Centre. In 2006-2007, he was the Astra Zeneca Clinical Trials Fellow with the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG).
He is currently an Assistant Professor of the Department of Oncology at McGill. His clinical expertise makes him a sought after lecturer on both the academic and medical fronts. His specialties include GU malignancies (prostate, bladder, testicle etc.), GI malignancies (stomach, pancreas, rectum, anal canal), and gynecological malignancies.
Dr. Niazi’s reserch interests include 3-D conformal radiotherapy (3D-CRT), intensity modulated radiotherapy (IMRT), total body irradiation (TBI), total skin electron irradiation (TSEI),
high dose rate (HDR) brachytherapy (Intraluminal: gynecological, rectal, oesophageal, and bronchial malignancies; Interstitial: breast, prostate, gynecological, and head and neck malignancies), stereotactic radiosurgery, and image guided radiotherapy (IGRT).
Vuong T, Waschke K, Niazi T, Richard C, Parent J , Liberman S, Charlebois P, Mayrand S, Loungnarath R, Stein B, Devic S. The value of Botox-A in acute radiation proctitis: Results from a phase I/II study using a 3 Dimension scoring system. Int J Radiat Oncol Biol Phy. July 23 2010. Hijal T, Al Hamad AA, Niazi T, Sultanem S, Bahoric B, Vuong T, Muanza T. Hypofractionated Radiotherapy and Adjuvant Chemotherapy Do Not Increase Radiation-Induced Dermatitis in Breast Cancer Patients. Current Oncology 2010. Volume 17, Number 5.Mok G, Niazi T, Heravi H, Vuong T, Aloyz R, Panansci L, Lee L, Muanza T. Effects of DNA-PK inhibition on DNA repair and cell survival in irradiated gastric cancer cell line. Cancer Research.